We found that the fourth-generation cephalosporin cefepime potently reduces tumor PDL1 in a wide variety of human and mouse tumor cell lines to phenocopy the recently described role of PDL1 in DNA damage repair [14,30]. The gene discussed is CD274; the disease is neoplasm.